Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Axim Biotechnologies (AXIM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7600 +14.47%
on 06/12/19
1.1900 -26.89%
on 05/22/19
-0.3000 (-25.64%)
since 05/17/19
3-Month
0.7600 +14.47%
on 06/12/19
1.9450 -55.27%
on 03/20/19
-1.0500 (-54.69%)
since 03/19/19
52-Week
0.4600 +89.13%
on 12/24/18
3.4900 -75.07%
on 08/07/18
-2.3200 (-72.73%)
since 06/19/18

Most Recent Stories

More News
FOX Business Features Opinion Article Authored by AXIM Biotechnologies, Inc. CEO on Why Legal CBD is Good for Consumers and the Economy

AXIM(R) Biotechnologies, Inc. (OTC: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), a world leader in cannabinoid research and product development, today announced that it has garnered news coverage...

MJNA : 0.0550 (+2.61%)
AXIM : 0.8700 (+1.16%)
AXIM(R) Biotechnologies, Inc. Signs Cannabinoid Product Supply Agreement with Healthcare Company for Clinical Trials on Treatment of Periodontitis

AXIM(R) Biotechnologies, Inc. (OTC: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), a world leader in cannabinoid research and product development, today announced that it has signed a cannabinoid...

AXIM : 0.8700 (+1.16%)
Cannastocks2019 Investor Conference & Webinar Now Available for On-Demand Viewing

NEW YORK , May 17, 2019 /PRNewswire/ -- Virtual Investor Conferences, in partnership with Midtown Partners & Co, LLC, today announced that the presentations from the Cannastocks2019 Q1 Virtual...

KSHB : 4.5100 (+3.98%)
EMHTF : 1.9977 (-3.49%)
AXIM : 0.8700 (+1.16%)
CNPOF : 2.7893 (+2.96%)
OGRMF : 8.3500 (+4.64%)
OGI.VN : 8.300 (-3.49%)
EMBI : 0.3175 (-6.59%)
SRUTF : 0.5293 (+1.79%)
GSRX : 1.1200 (-0.49%)
SPRWF : 1.1500 (unch)
SPR : 81.74 (-0.32%)
TGIF : N/A (unch)
TGIFF : 0.3410 (-0.03%)
MRMD : 2.4500 (+8.89%)
FIRE.TO : 1.53 (-0.65%)
EMH.VN : 2.640 (-4.00%)
ACRGF : 19.5600 (+2.95%)
AXIM(R) Biotechnologies Announces Additional Purchase Order for Nutraceutical Product With Leading Direct Selling Company

AXIM(R) Biotechnologies, Inc. (OTC: AXIM) ("AXIM(R) Biotech", "AXIM", or the "Company"), a world leader in cannabinoid research and development, today announced that the company has received an additional...

AXIM : 0.8700 (+1.16%)
AXIM(R) Biotechnologies to Present at Cannastocks 2019 Q1 Conference

AXIM(R) Biotechnologies, Inc. (OTC: AXIM) ("AXIM(R) Biotech", "Axim", or the "Company"), a world leader in cannabinoid research and development, today announced that the Company will be attending and presenting...

AXIM : 0.8700 (+1.16%)
Medical Marijuana, Inc. Major Investment Company Axim® Biotechnologies Files New U.S. Provisional Patent for Cannabis Gum as a Treatment for Migraine Symptoms

NEW YORK , May 14, 2019 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that the Company's...

MJNA : 0.0550 (+2.61%)
AXIM : 0.8700 (+1.16%)
Medical Marijuana, Inc. Major Investment Company Axim® Biotechnologies Files New U.S. Provisional Patent for Cannabis Gum as a Treatment for Migraine Symptoms

Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company's major investment company AXIM® Biotechnologies, Inc. (OTC:...

MJNA : 0.0550 (+2.61%)
AXIM : 0.8700 (+1.16%)
Cannastocks2019 Live-Stream Investor Conference & Webinar May 15th

NEW YORK , May 14, 2019 /PRNewswire/ -- Virtual Investor Conferences, in partnership with Midtown Partners & Co, LLC, today announced the agenda for the upcoming Cannastocks2019 Q1 Virtual lnvestor...

KSHB : 4.5100 (+3.98%)
EMHTF : 1.9977 (-3.49%)
AXIM : 0.8700 (+1.16%)
CNPOF : 2.7893 (+2.96%)
OGRMF : 8.3500 (+4.64%)
OGI.VN : 8.300 (-3.49%)
EMBI : 0.3175 (-6.59%)
SRUTF : 0.5293 (+1.79%)
GSRX : 1.1200 (-0.49%)
SPRWF : 1.1500 (unch)
SPR : 81.74 (-0.32%)
TGIF : N/A (unch)
TGIFF : 0.3410 (-0.03%)
MRMD : 2.4500 (+8.89%)
FIRE.TO : 1.53 (-0.65%)
EMH.VN : 2.640 (-4.00%)
ACRGF : 19.5600 (+2.95%)
AXIM(R) Biotechnologies Files New U.S. Provisional Patent for Cannabis Gum as a Treatment for Migraine Symptoms

AXIM(R) Biotechnologies, Inc. ("AXIM") ("the Company") ("AXIM Biotech") (OTC: AXIM), a world leader in cannabinoid research and development, today announced that the Company has filed a provisional patent...

AXIM : 0.8700 (+1.16%)
AXIM(R) Biotechnologies, Inc. Nutraceutical Division Receives Purchase Order for 50,000 Boxes of the Company's Proprietary CBD-Based Chewing Gum

AXIMBiotechnologies, Inc. ("AXIM") ("the Company") ("AXIM Biotech") (OTC: AXIM), a world leader in cannabinoid research and development, today announced that the nutraceutical division of the Company,...

AXIM : 0.8700 (+1.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

See More Share

Trade AXIM with:

Key Turning Points

2nd Resistance Point 0.9500
1st Resistance Point 0.9100
Last Price 0.8700
1st Support Level 0.8100
2nd Support Level 0.7500

See More

52-Week High 3.4900
Fibonacci 61.8% 2.3325
Fibonacci 50% 1.9750
Fibonacci 38.2% 1.6175
Last Price 0.8700
52-Week Low 0.4600

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar